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Abstract
Esophageal pressure can be used to approximate pleural pressure and might be clinically useful,
particularly in the obese e.g to guide mechanical ventilator settings in critical illness. However,
mediastinal artifact (the difference between true pleural pressure and esophageal pressure) may
limit acceptance of the measurement, and reproducibility of esophageal pressure measurements
remains unknown. Therefore, we aimed to assess the effect of body posture on esophageal
pressure in a cohort of obese but healthy subjects, some of whom had multiple measurements, to
address the clinical robustness of esophageal manometry. Twenty-five overweight and obese
subjects (BMI>25kg/m2) and 11 control lean subjects (BMI<25kg/m2) underwent esophageal
manometry with pressures measured seated and supine. Twenty overweight and obese subjects
had measurements repeated after ~1-2 weeks. Anthropometric data and sitting and supine
spirometry were recorded. The average end-expiratory esophageal pressures sitting and supine
were greater in the overweight and obese group than the lean group (sitting −0.1±2.1 vs.
−3.3±1.2cmH2O, supine 9.3±3.3 vs. 6.9±2.8cmH2O, respectively). The mean differences between
repeated measurements were small (−0.3 ± 1.7cmH2O sitting and −0.1 ± 1.5cmH2O supine).
Esophageal pressures correlated with a number of anthropometric and spirometric variables. In
conclusion, esophageal pressures are slightly greater in overweight and obese subjects than lean
subjects; but changes with position are similar in both groups. These data indicate that mediastinal
weight and postural effects on esophageal pressure are within a clinically acceptable range, and
suggest that esophageal manometry can be used to inform clinical decision making across wide
range of body types.
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Introduction
Lung inflation depends on transpulmonary pressure (PL), defined as the airway pressure
minus the pleural pressure (Ppl).[1] In certain clinical situations, such as in the care of
patients with the Acute Respiratory Distress Syndrome (ARDS), knowledge of pleural
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pressure can be helpful in preventing lung injury by minimizing over-distension (high PL) or
atelectrauma (low or negative PL).[2] However, direct measurements of pleural pressure in
humans are impractical, since intrapleural catheters carry risk for bleeding, infection, and
pneumothorax. Instead, most clinical practice to date has used plateau pressure (airway
pressure minus body surface pressure, usually atmospheric) as a surrogate marker of
transpulmonary pressure. Alternatively, we and others have used esophageal manometry as a
safe and relatively non-invasive approximation of pleural pressure.[3] A clinical trial using
an individualized, physiological approach to mechanical ventilation directed by estimated
transpulmonary pressure showed an improvement in oxygenation, and a trend toward
improved survival compared to standard ARDS Network management.[4] We found that
many patients had a higher than expected pleural pressure, and benefitted from high levels
of positive end-expiratory pressure (PEEP) to maintain a positive end-expiratory PL.
However, some experts were concerned that the high esophageal pressures we measured in
critical illness did not accurately reflect pleural pressures.[5, 6] Specifically, there has been
debate over the magnitude of what is sometimes called the “mediastinal artifact.”[7] Pleural
and esophageal pressure increase from the sitting to supine position. Pleural pressure
increases due to increased abdominal pressure transmitted across the diaphragm and into the
chest; the amount varying by the tension developed across the diaphragm. Functional
residual capacity (FRC) decreases as a result. However, esophageal pressure (PEs) increases
more with a position change than the directly measured pleural pressure. Measured in a
small number of subjects by Mead and Gaensler, PEs increased about 3cmH2O more with
position change than the simultaneously measured pleural pressure [3], a finding consistent
with subsequent studies.[8] This difference between mid-lung pleural pressure and
esophageal pressure when supine is thought to represent the compression of the esophagus
by mediastinal structures, such as the heart, and is referred to as the mediastinal artifact.
Some have argued that the magnitude of imprecision from these effects may be small in
relation to overall utility of PEs in critical illness; however, this assertion is based on data
from lean subjects.[9] The mediastinal artifact could be greater in overweight and obese
subjects due to mediastinal fat deposits.[10] Additionally, changes in technique (catheter
placement, balloon volume, etc) alter the measured pressure. In our prior study, we used a
relatively straightforward technique that would be easily reproducible if esophageal
manometry is found to be beneficial in the management of critically ill patients.
By measuring the change in PEs with changes in position, we sought to determine whether
positional effects were greater in overweight and obese patients than in lean subjects. If
changes in PEs are similar in both groups (obese and lean), it would further validate our
esophageal manometry technique. Furthermore, to be of clinical value, esophageal
manometry must not only be accurate, but also precise, reproducible and simple to measure.
Although manometry has been measured in a variety of cohorts, reproducibility has not
previously been reported to our knowledge. Therefore, we also sought to determine the
reproducibility of esophageal pressure measurements. Finally, with an exploratory intent, we
sought to determine whether anthropometric and spirometric measurements could explain
differences in PEsbetween subjects or changes that occur with position change. Ultimately,
any such relationship(s) could be useful in understanding the relative contribution of
physiology (e.g. obesity) and pathophysiology (e.g. pulmonary edema, increased abdominal
pressure) in a given patient.
Methods
Subjects
Overweight and obese (BMI>25kg/m2) subjects with and without asthma were recruited as
part of an ongoing, two night sleep study. Asthma, if present, had been diagnosed by a
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physician and was confirmed by provocative concentration of methacholine causing a 20%
fall in forced expiratory volume (PC20)<12mg/mL. Asthma subjects were clinically stable,
with no medication changes within the month prior to the study, no systemic
glucocorticoids, no emergency room visits or hospital admissions. No subject had smoked
within 3 months prior to the study, or had >10 pack-year smoking history. Other systemic,
respiratory, or esophageal disease, other than snoring or obstructive sleep apnea, was
excluded based on thorough history and physical examination. A second group of lean
(BMI<25kg/m2) healthy subjects was also recruited, based on the same exclusion criteria,
and studied on a single occasion. All subjects gave written, informed consent (approved by
local Institutional Review Board).
Measurements
Subject height, weight, and neck, chest, waist and hip circumferences were measured.
Spirometry was performed according to ATS criteria using a handheld spirometer (KoKo
spirometer, nSpire Health Inc., Longmont, CO) sitting and supine. Forced expiratory volume
in 1 second (FEV1) and forced vital capacity (FVC) are compared to age, gender, and height
matched controls to calculate percent predicted values.[11]
Esophageal manometry
Prior to insertion, both nostrils were sprayed with 0.05% oxymetazoline hydrochloride, a
decongestant, and the more patent nostril was then anesthetized with 4% lidocaine topical
spray. The balloon/catheter (Ackrad Labs Adult Esophageal Balloon Catheter Set, Trumbull,
CT) was passed via the nares 40cm and taped in place to prevent movement. The balloon is
thin-walled, 9.5cm long and with perimeter approximately 1.5cm, around an 86cm closed-
end catheter (inner diameter ~1mm). The balloon was emptied and then inflated with 1mL
of air using a double ground glass syringe, and connected to a pressure transducer
(DP103-26, Validyne Engineering Corp., Northridge, CA), previously calibrated using a
digital manometer (Product #302227, Respironics, Murraysville, PA) to ±20cmH2O relative
to atmosphere. Intra-thoracic (rather than intra-abdominal) placement was confirmed by the
presence of cardiac oscillations and expected pressure changes with spontaneous breathing
(negative esophageal pressure swing with inspiration) using established techniques.[4]
While the subject was seated, esophageal pressure was recorded during quiet breathing for
approximately 3 minutes. Measurements were repeated supine, with bed flat and one pillow.
Data were acquired on a 1401 plus interface and Spike2 software (Cambridge Electronic
Design Ltd, Cambridge, UK).
If well tolerated, esophageal manometry was repeated on the second sleep study night in the
overweight and obese group, ~1-2 weeks later. Repeat history and physical examination
confirmed no intercurrent illness.
Statistics and Data Analysis
During quiet breathing 10 consecutive breaths free from artifact (e.g. movement, sighs,
swallows) were selected for analysis. Esophageal pressure values were taken at end
expiration and at the nadir of pressure during inspiration. Reproducibility of measurements
was assessed by Pearson correlation coefficient. If data were available on both study nights,
these values were averaged prior to linear regression analysis. Linear regression was
performed for each dependent variable (sitting end-expiratory PEs, supine end-expiratory
PEs, difference between sitting and supine end-expiratory esophageal pressure, and
inspiratory pressure swings upright and supine) and independent variables: gender, BMI,
height, weight, circumferences, sitting and supine spirometry (FEV1, FVC, FEV1/FVC and
percent predicted FEV1 and FVC), and diagnosis of asthma. A multivariate regression was
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also performed with the same dependent variables, with independent variables chosen using
a backwards stepwise approach. . P value <0.05 was considered statistically significant.
Values are presented as mean ± standard deviation.
Results
Twenty-five overweight and obese subjects were recruited. Of these, 20 underwent repeat
esophageal manometry. Two subjects did not complete the second night of the study, while
3 subjects declined repeat esophageal balloon placement. Second night sitting data were not
available in one subject. As designed, average BMI for this group was >30kg/m2. For
comparison, 11 normal weight subjects were recruited and had esophageal manometry
performed one time. Subject characteristics are listed in Table #1.
Both sitting and supine PEs were higher in the overweight and obese cohort than in the lean
cohort (Figure #1). However, the difference in PEs with change from sitting to supine was
similar in both groups. In the overweight and obese group, there were no differences in end-
expiratory PEs in those with asthma versus no asthma. However, inspiratory pressures were
slightly less positive/more negative in the subjects with asthma (Table #2).
Data from subjects who had two measurements on separate nights were analyzed for
reproducibility. Pearson correlation coefficients (r) were 0.69 for sitting (n = 19) and 0.92
for supine (n = 20) esophageal pressures. Bland-Altman analysis showed good agreement
between the two measurements with mean difference between first and second
measurements −0.3 ± 1.7cmH2O sitting and −0.1 ± 1.5cmH2O supine (Figure #2).
Using all 36 subjects, univariate linear regression analysis showed that several factors
correlated with sitting and supine esophageal pressures (Table #3). As BMI, weight or body
circumference measurements increased, PEs increased. As spirometric measures (such as
FEV1% predicted and FVC% predicted) decreased, PEs increased. Sitting and supine
esophageal pressures were also correlated with one another (p<0.01, R2=0.36). There was no
effect of gender or the diagnosis of asthma on any measurement. Backward stepwise
multivariate regression analysis showed that waist circumference and sitting FVC%
predicted were most correlated with sitting esophageal pressure, while waist/hip ratio and
sitting FVC% predicted were most correlated with supine esophageal pressure. The
correlations were stronger with sitting esophageal pressure compared to supine esophageal
pressures. The difference in PEs between sitting and supine was not associated with any
measured variable.
Univariate linear regression analysis showed that pressure swings sitting and supine with
inspiration were correlated with BMI, but were more strongly correlated with predicted and
actual spirometric measurements (Table #4). Additionally, multivariate analysis showed that
FEV1/FVC ratio and FVC% predicted were most correlated with pressure swings during
quiet breathing.
Discussion
The novel findings of our study are: 1) using our esophageal manometry technique, that
although end-expiratory esophageal pressures are slightly higher in overweight and obese
subjects than lean subjects, the change in PEs from sitting to supine in obese subjects is not
greater than in lean subjects, 2) that repeated PEs measurements show good agreement, and
3) that several anthropometric and spirometric measurements correlate with PEs.
When examined as separate cohorts, PEs was greater in the overweight and obese subjects
than in lean subjects, both sitting and supine. The current work compares well with the
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existing literature, which suggests that PEs increases with increasing BMI (see Table #5).
Indeed, across all subjects, BMI was correlated with sitting and supine end-expiratory PEs.
Of note, the slightly higher pressures in the lean subjects in this study compared to Washko
may reflect the increased balloon volume used (1.0 vs. 0.5mL, respectively).[8] This volume
difference will affect the measured pressure slightly[12], increasing the measured pressure
by approximately 1-3cmH2O in this catheter-transducer system.[13]
Increased esophageal pressure in the overweight and obese likely reflects true increases in
pleural pressure, rather than an artifact of esophageal manometry in the overweight and
obese. For example, FRC, which represents a balance between lung and chest wall recoil
forces, is reduced even at moderate levels of obesity (BMI 30-35kg/m2) such as those
studied here, consistent with increased pleural pressures.[14-17] Pleural pressure is probably
increased in the obese due to both increased abdominal pressure, which is transmitted into
the chest, and increased chest wall mass. Increased abdominal pressure has been observed in
the obese[18], and documented to resolve with weight loss.[19] In the work by Babb and
colleagues, the increase in abdominal pressure appeared to explain most if not all of a
decrease in FRC in obese women.[16] In a cohort of critically ill patients, both gastric
pressure and bladder pressure explained some of the variance in end-expiratory esophageal
pressure.[9] Similarly, in a morbidly obese group anesthetized and about to undergo surgery,
gastric pressure and esophageal pressure were correlated at end expiration.[20] How much
of the increased pressure is transmitted to the chest across the diaphragm, and whether acute
changes in intra-abdominal pressure (e.g. pancreatitis, trauma) affect the pleural pressures
differently from chronic changes (e.g. obesity, ascites) is not known. For example, in some
human disease, such as COPD, and in animal models of obesity, diaphragm re-modeling
does occur.[21, 22]
Although we anticipated high esophageal pressures in the overweight and obese, we were
somewhat surprised that re-positioning subjects from sitting to supine increased PEs by a
similar amount in both the overweight and lean groups. Our results are similar to those from
Steier and colleagues, who reported a similar change in PEs from seated to supine in an
obese and a non-obese control group [8.8 and 7.1cmH2O (p value non-significant),
respectively].[23] That our data are similar to those from Steier and colleagues suggests that
our straight-forward and simple technique for measurement of esophageal pressure is valid.
Our data suggest that mediastinal artifact is not increased with increasing BMI, at least
within the mild to moderate range of obesity that we studied. However, an alternative
interpretation is that there is an increase in the mediastinal effect or artifact with obesity, but
this is offset by a decreased posture-related change in lung volume in the obese. As
discussed above, the change in PEs reflects both a change in intra-abdominal pressure and
lung volume that occurs with position change, and the weight of the mediastinum now atop
the esophageal balloon. In the subjects studied by Washko approximately half of the change
in esophageal pressure was attributed to lung volume changes. The relative contribution of
these effects may be different in overweight and obese subjects. For example, morbidly
obese subjects have much less or even zero lung volume change with position change, with
one study reporting that in obese subjects (BMI 44±3kg/m2) FRC decreased only 70mL
sitting to supine, compared to 730mL in a leaner (BMI<27kg/m2) control group.[24, 25]
Even in overweight and more modestly obese subjects, position change probably has a
reduced effect on lung volume.[15] Unfortunately, whether this finding reflects a lower
starting position on the pressure-volume curve of the total respiratory system, or reflects a
similar smaller change in abdominal pressure with position change in the overweight and
obese is not known. Simultaneous measurements of gastric or bladder pressures during our
study would have been helpful to answer these questions. Any increase in mediastinal
‘artifact’ in the overweight and obese would presumably be due to increased mediastinal fat.
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Most thoracic fat is extra-pleural, with the bulkiest deposits of the thorax in the
mediastinum.[10]
To our knowledge, the current study is the first to assess reproducibility of esophageal
manometry. The standard deviation of the measurements was <2cmH2O, with 95%
confidence interval approximately ±3cmH2O. This degree of precision, if similar in other
clinical settings including critical illness, should be adequate for repeated measurements, if
necessary. Put another way, differences greater than this amount should suggest true
changes in (patho-) physiology. Furthermore, esophageal manometry seems as robust as
other commonly used ICU parameters, such as pulmonary artery catheter and bladder
measurements of intra-abdominal pressure.[26] In terms of clinical use in the ICU, our data
provide guidance for ICU practitioners as to a normal value of esophageal pressure in
subjects with mild to moderate obesity. Our healthy obese controls had lower esophageal
pressures than an ICU cohort with similar BMI.[13] The additional increase in esophageal
pressure likely reflects some aspect of critical illness, such as fluid accumulation (e.g.
pulmonary edema, which would increase the magnitude of gravitational gradient through the
lung) or elevated intra-abdominal pressure, which is common in ICU patients.[27] Overall,
we believe esophageal manometry useful in the management of ventilated ICU patients, as it
can both identify elevated pleural pressure as a cause or contributor of hypoxemic
respiratory failure, and provide reassurance that the correct treatment with increased positive
end expiratory pressure (PEEP) does not cause lung over-distension.
Several anthropometric and spirometric measurements correlated with PEs. Although BMI
correlated with esophageal pressure, direct measurements of abdominal girth, such as waist
circumference and waist/hip ratio were more predictive of esophageal pressures. Again,
these findings may further emphasize the importance of intra-abdominal pressure on intra-
thoracic pressures, since measurements of abdominal girth, including waist-hip ratio and
sagittal abdominal diameter, have been previously found to correlate with intra-abdominal
pressure.[28, 29] Along these lines, anthropometric and spirometric measurements explained
66% of the variance in the sitting esophageal pressure. However, these measurements
explained less of the variance (only 33%) in the supine position, perhaps because
anthropometric measurements were made while subjects were upright. As expected,
decreasing FVC and FVC% predicted were associated with increased esophageal pressure.
As above, this finding may simply reflect that FVC decreases with obesity. However, as
shown in the multivariate regression, the addition of FVC improved the robustness of our
model, suggesting that lung volumes do capture additional information about the effects of
obesity on the respiratory system. Overall, however, these measurements predict only a
portion of the variance of esophageal pressures in healthy controls. Thus, in most clinical
situations requiring estimation of pleural pressure at end-expiration, esophageal manometry
will likely be required.
At first glance, it seems surprising that many of our healthy overweight subjects appear to
have a negative transpulmonary pressure (esophageal pressure greater than airway pressure)
at end-expiration in the supine position. Three factors may help explain these findings. First,
PEs is a measure of local pleural pressure, which varies with height along the gravitational
gradient. Pleural and esophageal pressures from dependent lung regions are greater than the
same measurements from non-dependent regions – although this gradient is usually small in
healthy lungs, somewhere between 0.2 – 1cmH2O/cm.[30] The average pleural pressure, or
the pleural pressure for a large portion of lung, may still be negative. Second, as discussed,
the effect of mediastinal structures may overestimate the true local pleural pressure by about
3-5cmH2O when supine. Third, negative transpulmonary pressure could also imply that
alveolar and airway pressure have not equilibrated – which could be due to tidal airway
closure or expiratory flow limitation. This phenomenon can occur at low lung volumes due
Owens et al. Page 6
Obesity (Silver Spring). Author manuscript; available in PMC 2013 June 01.
$watermark-text
$watermark-text
$watermark-text
to obesity and increases with normal aging.[31, 32] Very high local pleural pressure
suggests that airway closure might be occurring in our obese subjects (who presumably
breathe at low lung volumes), especially supine. Indeed, intrinsic positive end-expiratory
pressure (PEEPi) has been reported in severe obesity (BMI>40kg/m2) ostensibly in the
setting of decreased FRC and airway closure.[23, 33] We were able to look for PEEPi when
our subjects were supine and flow was measured, by comparing the change in PEs from end-
expiratory baseline prior to the start of inspiratory flow. Intrinsic PEEP was observed in 5 of
the overweight and obese group, 4 of whom also had asthma. The single subject without
asthma (and no obstruction on spirometry) but with PEEPi in the supine position had a BMI
of 42.5kg/m2.
Although we were mostly focused on end-expiratory pressures, inspiratory pressure swings
increased with increasing BMI (and several other markers of obesity), a finding reported by
others as well.[23] However, in this cohort that included asthmatics, pressure swings were
also correlated with markers of asthma severity, such as the FEV1/FVC ratio.
Limitations
There are limitations to our study. First, the esophageal balloon was placed according to our
established protocol,[4] using cardiac oscillations and inspiratory falls in pleural pressure to
guide placement, rather than confirming placement with radiology or the occlusion test.
Imaging could have been useful to confirm balloon placement and to assess adjacent areas
of lung parenchyma which may be at risk of compression/collapse.[34] However, although
differences of a few centimeters in balloon placement in the esophagus will change
measured esophageal pressure, the magnitude of this change is negligible.[35] Furthermore,
the long partially-inflated balloon used will minimize differences due to placement, as the
air bubble will always flow towards the area of least pressure along the entire length of the
balloon. We did not perform the occlusion test,[36] instead focusing on an easily
reproducible method that could be applied across broad patient populations, including ICU
patients who may not be spontaneously breathing. Second, we did not measure abdominal
pressure or absolute lung volumes. Both measurements would have been useful to confirm
some of the speculations and conclusions we have made from our data. Third, we included
subjects with asthma, who were participating in another ongoing study. However, asthma
was generally well controlled with minor obstructive abnormalities on spirometry. Again,
although the diagnosis of asthma impacted inspiratory pressure swings, it did not appear to
affect expiratory esophageal pressure measurements.
Conclusion
These data confirm that esophageal pressures are elevated in the overweight and obese.
However, the change in PEs with position change using our esophageal manometry
technique is similar in overweight and obese and lean subjects. Repeated measurements
show good agreement. Taken together, these results suggest that our easily reproducible
esophageal manometry technique can be used to inform clinical decision making across
wide range of body types. Some anthropometric and spirometric measurements that may
relate to abdominal pressures correlate with esophageal pressure. However, these
measurements only explain a portion of the variance of PEs and in clinical situations
requiring estimation of pleural pressure, esophageal manometry remains the gold standard.
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Figure 1.
End expiratory esophageal pressure sitting and supine for each subject. Lean (▲) and
overweight and obese (■), with each group mean in black.
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Figure 2.
Bland-Altman plots of end-expiratory esophageal pressures (sitting, A and supine, B) from
two separate measurements. Solid line is bias, and dotted lines represent the 95% confidence
interval.
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Table 1
Subject characteristics and spirometry
Overweight and Obese Normal
WeightTotal No Asthma Asthma
Sample Size
(M/F) 25 (9/16) 10 (6/4) 15 (3/12) 11 (7/4)
Age (years) 35.6 ± 12.4 35.7 ± 12.2 35.5 ± 13.0 32.5 ± 11.2
BMI (kg/m2) 33.3 ± 5.7 34.1 ± 5.8 30.7 ± 5.8 22.5 ± 2.1†
Seated
Spirometry
FEV1% predicted 82.7 ± 17.6 96.1 ± 11.7 73.7 ± 15.1* 96.5 ± 11.8†
FVC% predicted 90.6 ± 15.3 99.1 ± 12.3 84.9 ± 14.6* 102.7 ± 7.0†
FEV1/FVC 0.77 ± 0.09 0.81 ± 0.04 0.74 ± 0.10 0.79 ± 0.09
Supine
Spirometry
FEV1% predicted 76.4 ± 18.1 88.7 ± 12.2 67.6 ± 16.7* 88.0 ± 11.1
FVC% predicted 85.1 ± 16.6 93.8 ± 12.0 78.9 ± 16.9* 97.5 ± 8.7†
FEV1/FVC 0.75 ± 0.08 0.79 ± 0.05 0.73 ± 0.10 0.77 ± 0.08
*p<0.05 compared to No Asthma.
†p <0.05 Normal weight compared to Overweight and Obese
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Table 3
Univariate regression analysis of end-expiratory esophageal pressures
Sitting PEs Supine PEs
R2 R2
BMI 0.49# 0.19#
Weight 0.35# 0.16*
Height 0.06 0.02
Gender 0.07 0
Asthma dx 0.10 0.01
Body
Measurements
Neck 0.27# 0.13*
Chest 0.39# 0.22#
Waist 0.51# 0.25#
Hip 0.37# 0.11*
Waist/Hip 0.23# 0.23#
Spirometry
Sitting
FEV1 0.25# 0.13*
FEV1 %pred 0.23# 0.15*
FVC 0.36# 0.16*
FVC %pred 0.48# 0.24#
FEV1/FVC 0 0
Spirometry
Supine
FEV1 0.23# 0.13*
FEV1 %pred 0.21# 0.16*
FVC 0.33# 0.16*
FVC %pred 0.41# 0.22#
Multivariate regression analysis of end-expiratory esophageal pressures
Coefficient Standard Error of
coefficient Standardized coefficient
Sitting
Waist circumference 0.067 0.016 0.50
FVC %predicted,
sitting −0.071 0.021 −0.42
p = <0.001 R2 = 0.66
Supine
Waist/hip ratio 12.64 5.97 0.337
FVC %predicted,
sitting −0.08 0.037 −0.346
p = 0.002 R2 = 0.33
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*p<0.05
#p<0.01
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Table 4
Univariate regression analysis of inspiratory pressure swings (Δ PEs)
Sitting Δ PEs Supine Δ PEs
R2 R2
BMI 0.13* 0.19*
Weight 0.08 0.07
Height 0.03 0.13*
Gender 0.04 0.06
Asthma dx 0.27* 0.31*
Body
Measurements
Neck 0.14* 0.22#
Chest 0.09 0.17*
Waist 0.16* 0.25*
Hip 0.10 0.15*
Waist/Hip 0.11 0.16*
Spirometry
Sitting
FEV1 0.29* 0.48*
FEV1 %pred 0.43* 0.52*
FVC 0.2* 0.39*
FVC %pred 0.29# 0.42*
FEV1/FVC 0.2* 0.17*
Spirometry
Supine
FEV1 0.25# 0.43*
FEV1 %pred 0.33# 0.47*
FVC 0.19* 0.37*
FVC %pred 0.27# 0.39*
Multivariate regression analysis of inspiratory pressure swings
Coefficient Standard Error of
coefficient Standardized coefficient
Sitting FEV1/FVC −11.26 3.39 −0.42
FVC %predicted,
sitting −0.087 0.021 −0.52
p = <0.001 R2 = 0.47
Supine
FEV1/FVC −17.19 5.05 −0.39
FVC %predicted,
sitting −0.08 0.0.14 −0.63
p = <0.001 R2 = 0.57
*p<0.05
#p<0.01
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Table 5
Published esophageal manometry data.
Study Subjects BMI (kg/m2)
PEs
Supine Sitting
Washko(6) Healthy, lean 24.5 ± 3.7 3.3 ± 3.2 -3.7 ± 2.0
Behazin(15) Surgical,paralyzed, lean 25.2 ± 2.8 6.9 ± 3.1
Healthy, lean 22.5 ± 2.1 6.9 ± 2.8 -3.3 ± 1.2
Current study
Healthy,
overweight and
obese
33.3 ± 5.7 9.3 ± 3.3 -0.1 ± 2.1
Healthy, lean 23.6 ± 3.7 5.1 ± 3.5 -2.0 ± 2.7
Steier(18) Healthy, morbidly
obese 42.8 ± 8.6 12.8 ± 4.8 4.0 ± 4.2
Behazin(15) Surgical,paralyzed, obese 48.5 ± 8.9 12.5 ± 3.9
Talmor(10) ICU, acute
respiratory failure 31.0 ± 10.0 17.5 ± 5.7
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